These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 76475)

  • 21. Acute leukemia in childhood: comparison of immunological histochemical and clinical findings.
    Winterleitner H; Krepler P; Knapp W
    Padiatr Padol; 1980; 15(3):221-32. PubMed ID: 6968053
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Membrane markers in lymphoproliferative disorders.
    Lancet; 1975 Mar; 1(7908):670-1. PubMed ID: 47088
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunological classification of leukemias and non Hodgkin's hematosarcomas based on T and B cell membrane markers with special reference to null "cell" disorders.
    Belpomme D; Lelarge N; Joseph R; Mathe G
    Eur J Cancer (1965); 1977; 13(4-5):311-9. PubMed ID: 326549
    [No Abstract]   [Full Text] [Related]  

  • 28. T and B lymphocyte membrane markers in cells from patients with leukemia and lymphoma.
    Mendes NF; Musatti CC; Tolnai ME
    Int Arch Allergy Appl Immunol; 1974; 46(5):695-706. PubMed ID: 4276399
    [No Abstract]   [Full Text] [Related]  

  • 29. The nature of childhood leukemia and lymphoma.
    Kersey JH; Gajl-Peczalska KJ; Coccia PF; Nesbit ME
    Am J Pathol; 1978 Feb; 90(2):487-95. PubMed ID: 304675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null cell disorders.
    Belpomme D; Lelarge N; Feuilhade de Chauvin F; Joseph R; Mathé G
    Recent Results Cancer Res; 1976; (56):98-110. PubMed ID: 1087447
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte surface markers in human disease.
    Townes AS; Postlethwaite AE
    Adv Intern Med; 1977; 22():97-119. PubMed ID: 320850
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigens of the thymus.
    Schlesinger M
    Prog Allergy; 1972; 16():214-99. PubMed ID: 4117678
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic characterization of chronic lymphocytic leukemia cells.
    Whiteside TL; Winkelstein A; Rabin BS
    Cancer; 1977 Mar; 39(3):1109-18. PubMed ID: 303143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
    Dutta SK; Novilla MN; Bumgardner MK; Ingling A
    Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunologic diagnosis of variants of chronic lymphoid leukemia and lymphosarcomas].
    Samoĭlova RS; Ol'shevskaia EV; Polianskaia AM
    Ter Arkh; 1981; 53(11):73-8. PubMed ID: 7041315
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological monitoring utilizing novel probes.
    Stewart CC; Stewart SJ
    Ann N Y Acad Sci; 1993 Mar; 677():94-112. PubMed ID: 8494251
    [No Abstract]   [Full Text] [Related]  

  • 38. [Data obtained by the study of membrane markers of human lymphoid cells in disease].
    Seligmann M; Preud'homme JL; Brouet JC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1798-807. PubMed ID: 337473
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 40. Surface characteristics of lymphoma cells in relation to treatment, response and survival.
    Stathopoulos G; Kay HE; Hamlin IM; McKay AM
    Eur J Cancer (1965); 1978 May; 14(5):479-83. PubMed ID: 306344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.